Serventi-Seiwerth R - Search Results

1

Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric Study.

Ostojic A, Sertic D, Roncevic P, Peric Z, Granic P, Matic N, Basic-Kinda S, Serventi-Seiwerth R, Radman I, Zadro R, Nemet D. Ostojic A, et al. Clin Lymphoma Myeloma Leuk. 2016 Aug;16(8):472-6. doi: 10.1016/j.clml.2016.04.003. Epub 2016 May 5. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27245313

2

Low-dose Ara-C in the treatment of myelodysplastic syndromes.

Bogdanić V, Labar B, Mrsić M, Nemet D, Serventi-Seiwerth R. Bogdanić V, et al. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:26-7. Bone Marrow Transplant. 1989. PMID: 2697395 Clinical Trial. No abstract available.

3

Allogeneic stem cell transplantation in treatment of aggressive lymphomas: case series.

Labar B, Bogdanić V, Nemet D, Mrsić M, Serventi-Seiwerth R, Sertić D, Golubić-Cepulić B, Vrtar M, Santek F, Batinić D, Mikulić M, Pulanić D. Labar B, et al. Croat Med J. 2002 Oct;43(5):565-8. Croat Med J. 2002. PMID: 12402397 Free article.

4

[Treatment of chronic myeloid leukemia with imatinib in the accelerated stage of the disease].

Bulum J, Labar B, Mikulić M, Bogdanić V, Sertić D, Nemet D, Krecak-Gverić V, Kovacević J, Serventi-Seiwerth R, Mrsić-Davidović S, Zadro R, Boban D. Bulum J, et al. Lijec Vjesn. 2003 Jul-Aug;125(7-8):176-9. Lijec Vjesn. 2003. PMID: 14692090 Clinical Trial. Croatian.

5

Patient with immunoproliferative disease and lung carcinoma: a case report.

Radman I, Sucić M, Serventi-Seiwerth R, Boban D, Marković-Glamocak M, Ries S, Gjadrov-Kuvezdić K, Petković D, Jakić-Razumović J, Sćukanec-Spoljar M, Seiwerth S, Sucić Z, Papa J. Radman I, et al. Diagn Cytopathol. 2005 Feb;32(2):97-102. doi: 10.1002/dc.20176. Diagn Cytopathol. 2005. PMID: 15637671

6

[Rituximab in the treatment of indolent non-Hodgkin's lymphoma].

Aurer I, Mitrović Z, Radman I, Kovacević-Metelko J, Nemet D, Serventi-Seiwerth R, Stern-Padovan R, Jakic-Razumović J, Nola M, Zupancić-Salek S, Sertić D, Labar B. Aurer I, et al. Lijec Vjesn. 2004 Nov-Dec;126(11-12):307-11. Lijec Vjesn. 2004. PMID: 16082888 Clinical Trial. Croatian.

7

Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.

Aurer I, Mitrović Z, Nemet D, Radman I, Sertić D, Serventi-Seiwerth R, Stern-Padovan R, Santek F, Nola M, Mrsić M, Labar B. Aurer I, et al. J Chemother. 2008 Oct;20(5):640-4. doi: 10.1179/joc.2008.20.5.640. J Chemother. 2008. PMID: 19048695 Clinical Trial.

8

[Current approach to diagnosis and treatment of acute leukemia in adults].

Labar B, Nemet D, Sucić M, Batinić D, Zadro R, Mrsić S, Serventi-Seiwerth R, Sertić D, Mikulić M, Duraković N. Labar B, et al. Acta Med Croatica. 2008 Oct;62(4):403-8. Acta Med Croatica. 2008. PMID: 19205417 Croatian.

9

Biological features and outcome of biphenotypic acute leukemia: a case series.

Mikulic M, Batinic D, Sucic M, Davidovic-Mrsic S, Dubravcic K, Nemet D, Serventi-Seiwerth R, Sertic D, Labar B. Mikulic M, et al. Hematol Oncol Stem Cell Ther. 2008 Oct-Dec;1(4):225-30. doi: 10.1016/s1658-3876(08)50009-4. Hematol Oncol Stem Cell Ther. 2008. PMID: 20058478 Free article.

10

Collection and composition of autologous peripheral blood stem cells graft in patients with acute myeloid leukemia: influence on hematopoietic recovery and outcome.

Raos M, Nemet D, Bojanić I, Sertić D, Batinić D, Dusak V, Dubravcić K, Mazić S, Serventi-Seiwerth R, Mrsić M, Golubić-Cepulić B, Labar B. Raos M, et al. Coll Antropol. 2010 Mar;34(1):105-15. Coll Antropol. 2010. PMID: 20437639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters